Legend Financial Advisors, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Legend Financial Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$478.3 - $607.98 $601,701 - $764,838	-1,258 Closed	0 $0
Q3 2020 Nov 12, 2020	SELL	$544.75 - $658.21 $11,439 - $13,822	-21 Reduced 1.64%	1,258 $705,000
Q2 2020 Aug 18, 2020	BUY	$493.32 - $643.92 $45,878 - $59,884	93 Added 7.84%	1,279 $798,000
Q1 2020 May 15, 2020	BUY	$336.18 - $494.43 $398,709 - $586,393	1,186 New	1,186 $579,000

1,529

84.1M

1.22M

1.51M

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

Get notified when there are updates to the investment portfolio of Legend Financial Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Legend Financial Advisors, Inc. with notifications on news.